The eosinophilic esophagitis (EoE) histologic scoring system (HSS) displays high responsiveness and similar performance to peak eosinophil count (PEC), reports a study. In addition, EoE-HSS is more highly associated with changes in overall histologic activity.
A team of investigators obtained histopathology slides from EoE patients at baseline and after 8 weeks of treatment with swallowed topical budesonide or elimination diet. Two blinded gastrointestinal pathologists scored biopsies on the EoE-HSS, PEC, and 100-mm visual analogue scale (VAS) of overall histologic severity. Change was defined as an improvement by ≥0.5 SD in baseline VAS.
The investigators quantified responsiveness using the standardized effect size (SES) and the probability that the index distinguishes a patient with improvement from a patient without improvement, which is the area under the receiver operating characteristic curve (AUC). They also evaluated longitudinal validity using Pearson correlations between changes in EoE-HSS and both PEC and VAS.
The EoE-HSS grade (SES, 2.18, 95 percent confidence interval [CI], 1.46‒2.88; AUC, 0.73, 95 percent CI, 0.57‒0.84) and stage (SES, 2.07, 95 percent CI, 1.37‒2.77; AUC, 0.73, 95 percent CI, 0.58‒0.84) were highly responsive and performed similarly to PEC (SES, 1.44, 95 percent CI, 0.80‒2.07; AUC, 0.73, 95 percent CI, 0.58‒0.84).
In addition, the EoE-HSS grade and stage had a stronger association with changes in VAS (grade: 0.92, 95 percent CI, 0.86‒0.95; stage: 0.89, 95 percent CI, 0.81‒0.94) than with changes in PEC (grade: 0.74, 95 percent CI, 0.58‒0.85; stage: 0.66, 95 percent CI, 0.47‒0.80).